(UroToday.com) The American Urologic Association (AUA) annual meeting included a late-breaking abstract session with a presentation by Dr. Andrei Iagaru discussing the prospective study of 68Ga-RM2 PET/MRI in biochemically recurrent prostate cancer and negative conventional imaging.